SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-085813
Filing Date
2024-08-05
Accepted
2024-08-05 16:05:14
Documents
2
Period of Report
2024-08-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2420761-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2420761-1_3seq1.xml 3 1594
2 EXHIBIT 24 tm2420761d1_ex-24.htm EX-24 7527
  Complete submission text file 0001104659-24-085813.txt   10671
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Issuer) CIK: 0001400118 (see all company filings)

IRS No.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TREVENA, INC. 1018 WEST 8TH AVENUE KING OF PRUSSIA PA 19406
Business Address
Phillips Anne M. (Reporting) CIK: 0001627680 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41742 | Film No.: 241174713